Michelle LaFond

Vice President of Preclinical Manufacturing and Process Development at Regeneron

Keynote

Michelle joined Regeneron 25 years ago as a member of the Bioreactor Scale-Up & Development group within Preclinical Manufacturing and Process Development. She has focused her career on scale-up of CHO-expressed products (recombinant proteins, monoclonal antibodies) to pilot scale for preclinical studies, process characterization and robustness testing for second generation processes, technology transfer to manufacturing scales, and is skilled in troubleshooting issues that arise during process scale-up. In 2019, to advance the department’s use of data for analysis, visualization, modeling, and control, Michelle formed a group focused on Process Data Enablement and Analytics. Michelle is managing her department’s fourth expansion, leading design of state-of-the-art laboratories and infrastructure to support development capabilities.